Results 281 to 290 of about 11,359 (301)

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)

Signal Transduction and Targeted Therapy, 2022
Chenyang Zhao
exaly  

Gut bacteria alleviate smoking-related NASH by degrading gut nicotine

Nature, 2022
, Lulu Sun, Yuhong Luo
exaly  

Implementation in Mixed Nash Equilibrium [PDF]

, 2012
We study the gains from trade in a model with endogenously variable markups. We show that the pro-competitive gains from trade are large if the economy is characterized by (i) extensive misallocation, i.e., large ineciencies associated with markups, and (ii) a weak pattern of cross-country comparative advantage in individual sectors.
openaire  

A researcher’s guide to preclinical mouse NASH models

Nature Metabolism, 2022
Suchira Gallage, , Enrico Focaccia
exaly  

Maladaptive regeneration — the reawakening of developmental pathways in NASH and fibrosis

Nature Reviews Gastroenterology and Hepatology, 2020
Changyu Zhu, Ira A Tabas, Robert F Schwabe   +2 more
exaly  

From NASH to HCC: current concepts and future challenges

Nature Reviews Gastroenterology and Hepatology, 2019
Quentin M Anstee, Frcp, Helen L Reeves, Olivier Govaere   +2 more
exaly  

Triggering and resolution of inflammation in NASH

Nature Reviews Gastroenterology and Hepatology, 2018
Daniel Cabrera, Marco Arrese, Ariel E Feldstein   +2 more
exaly  

Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

Nature Reviews Gastroenterology and Hepatology, 2018
Vincent Wai-Sun Wong, Victor de Lédinghen, Grace Lai-Hung Wong   +2 more
exaly  

Nash Implementation

2006
openaire   +1 more source

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Nature Medicine, 2019
Mohsen Malehmir, Dominik Pfister, Suchira Gallage   +2 more
exaly